We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$112M
2
RY icon
Royal Bank of Canada
RY
+$44.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$38.9M
5
MRK icon
Merck
MRK
+$31.7M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
301
Zimmer Biomet
ZBH
$18.8B
$6.68M 0.05%
54,856
+3,691
+7% +$412K
AKAM icon
302
Akamai
AKAM
$15.6B
$6.65M 0.05%
56,166
+6,762
+14% +$752K
WFG icon
303
West Fraser Timber
WFG
$5.21B
$6.49M 0.04%
75,535
-20,169
-21% -$1.49M
PCRX icon
304
Pacira BioSciences
PCRX
$1.04B
$6.48M 0.04%
191,901
+40,000
+26% +$1.17M
MDGL icon
305
Madrigal Pharmaceuticals
MDGL
$12.6B
$6.25M 0.04%
27,000
-2,000
-7% -$350K
OKTA icon
306
Okta
OKTA
$23.8B
$6.24M 0.04%
68,942
+3,660
+6% +$279K
PK icon
307
Park Hotels & Resorts
PK
$3.08B
$6.21M 0.04%
+405,884
New +$5.59M
CI icon
308
Cigna
CI
$78.4B
$6.12M 0.04%
20,432
-2,018
-9% -$590K
WDAY icon
309
Workday
WDAY
$41.5B
$6.09M 0.04%
22,071
-16,806
-43% -$4M
XIFR
310
XPLR Infrastructure LP
XIFR
$1.04B
$6.08M 0.04%
199,850
-166,316
-45% -$4.24M
ORLY icon
311
O'Reilly Automotive
ORLY
$75.1B
$6.03M 0.04%
95,160
+48,270
+103% +$3.05M
RUN icon
312
Sunrun
RUN
$2.26B
$6.02M 0.04%
+306,528
New +$3.89M
VTR icon
313
Ventas
VTR
$47.5B
$6.01M 0.04%
120,652
-87,964
-42% -$3.94M
SCHW
314
Charles Schwab
SCHW
$182B
$5.97M 0.04%
86,730
-8,629
-9% -$498K
SHLS icon
315
Shoals Technologies Group
SHLS
$1.33B
$5.94M 0.04%
+381,988
New +$5.78M
EVH icon
316
Evolent Health
EVH
$371M
$5.9M 0.04%
+178,663
New +$5.06M
POWI icon
317
Power Integrations
POWI
$3.15B
$5.9M 0.04%
71,826
-26,321
-27% -$2.02M
VRSK icon
318
Verisk Analytics
VRSK
$27.9B
$5.89M 0.04%
24,672
+11,827
+92% +$2.8M
BBY icon
319
Best Buy
BBY
$19B
$5.79M 0.04%
74,022
+59,978
+427% +$4.22M
BEAM icon
320
Beam Therapeutics
BEAM
$2.68B
$5.79M 0.04%
212,665
+83,000
+64% +$2.06M
CPNG icon
321
Coupang
CPNG
$27.2B
$5.76M 0.04%
355,800
-172,200
-33% -$2.84M
COO icon
322
Cooper Companies
COO
$14.2B
$5.74M 0.04%
60,720
+4,048
+7% +$340K
ARWR icon
323
Arrowhead Research
ARWR
$12.1B
$5.66M 0.04%
185,054
-35,000
-16% -$929K
INBX
324
DELISTED
Inhibrx, Inc. Common Stock
INBX
$5.13M 0.04%
135,069
-20,000
-13% -$429K
WY icon
325
Weyerhaeuser
WY
$17.6B
$5.09M 0.04%
146,474
-151,428
-51% -$4.71M
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.